Logos Global Management LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Logos Global Management LP disclosed 47 US equity positions worth $854.6m in its Q4 2024 13F filing. The largest position was IDYA at 9.0% of the reported book, followed by JANX and RVMD. Against the Q3 2024 filing, it opened 17 new positions, added to 11 and reduced 9 among the top 47 holdings.
What did Logos Global Management LP own in Q4 2024? Top 47 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 9.0% | $77.1m | 3,000,000 | 43% | added |
| 2 | JANX JANUX THERAPEUTICS INC | Healthcare | 7.8% | $66.9m | 1,250,000 | 25% | added |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 7.4% | $63.4m | 1,450,000 | 21% | added |
| 4 | CYTK CYTOKINETICS INC | Healthcare | 5.0% | $42.3m | 900,000 | 125% | added |
| 5 | VERA VERA THERAPEUTICS INC | Healthcare | 4.3% | $37.0m | 875,000 | 75% | added |
| 6 | BNTX BIONTECH SE | Healthcare | 4.0% | $34.2m | 300,000 | – | new |
| 7 | MERUS N V | 3.7% | $31.5m | 750,000 | 30% | added | |
| 8 | ERAS ERASCA INC | Healthcare | 3.7% | $31.4m | 12,500,000 | 15% | added |
| 9 | INSM INSMED INC | Healthcare | 3.6% | $31.1m | 450,000 | – | new |
| 10 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 3.5% | $29.9m | 3,500,000 | 0% | held |
| 11 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.2% | $27.3m | 200,000 | – | new |
| 12 | DSGN DESIGN THERAPEUTICS INC | Healthcare | 3.0% | $26.0m | 4,217,627 | 0% | held |
| 13 | PCVX VAXCYTE INC | Healthcare | 2.9% | $24.6m | 300,000 | 0% | held |
| 14 | AKERO THERAPEUTICS INC | 2.6% | $22.3m | 800,000 | 0% | held | |
| 15 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 2.5% | $21.6m | 175,000 | – | new |
| 16 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 2.2% | $19.0m | 700,000 | -44% | reduced |
| 17 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 2.2% | $18.7m | 3,208,875 | 0% | held |
| 18 | 2655787D BLUEPRINT MEDICINES CORP | 2.0% | $17.4m | 200,000 | – | new | |
| 19 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 2.0% | $17.4m | 1,000,000 | -9% | reduced |
| 20 | APLSUSD APELLIS PHARMACEUTICALS INC | 1.9% | $16.0m | 500,000 | – | new | |
| 21 | SLNOEUR SOLENO THERAPEUTICS INC | 1.8% | $15.7m | 350,000 | – | new | |
| 22 | ALKS ALKERMES PLC | Healthcare | 1.7% | $14.4m | 500,000 | – | new |
| 23 | APGE APOGEE THERAPEUTICS INC | Healthcare | 1.6% | $13.6m | 300,000 | – | new |
| 24 | ARVN ARVINAS INC | Healthcare | 1.6% | $13.4m | 700,000 | 75% | added |
| 25 | ANNX ANNEXON INC | Healthcare | 1.5% | $13.1m | 2,550,000 | -2% | reduced |
| 26 | IRON DISC MEDICINE INC | Healthcare | 1.5% | $12.7m | 200,000 | -79% | reduced |
| 27 | SYRE SPYRE THERAPEUTICS INC | 1.4% | $11.6m | 500,000 | 150% | added | |
| 28 | EWTX EDGEWISE THERAPEUTICS INC | 1.2% | $10.7m | 400,000 | -11% | reduced | |
| 29 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.2% | $10.6m | 450,000 | 181% | added |
| 30 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 1.2% | $9.9m | 750,000 | – | new |
| 31 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 1.0% | $8.8m | 245,000 | – | new |
| 32 | YMABUSD Y-MABS THERAPEUTICS INC | 0.9% | $7.8m | 1,000,000 | 25% | added | |
| 33 | IMVT IMMUNOVANT INC | Healthcare | 0.9% | $7.4m | 300,000 | -73% | reduced |
| 34 | GERN GERON CORP | Healthcare | 0.8% | $7.1m | 2,000,000 | – | new |
| 35 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 0.6% | $5.5m | 2,222,222 | – | new |
| 36 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.6% | $5.2m | 1,250,000 | -55% | reduced |
| 37 | CATBUSD ASTRIA THERAPEUTICS INC | 0.5% | $4.5m | 500,000 | 0% | held | |
| 38 | UNCY UNICYCIVE THERAPEUTICS INC | 0.5% | $4.0m | 5,078,927 | 0% | held | |
| 39 | AEROVATE THERAPEUTICS INC | 0.4% | $3.7m | 1,400,000 | – | new | |
| 40 | RAPP RAPPORT THERAPEUTICS INC | 0.4% | $3.7m | 208,910 | 0% | held | |
| 41 | ATYR ATYR PHARMA INC | Healthcare | 0.4% | $3.6m | 1,000,000 | -50% | reduced |
| 42 | ALLKGUSD ALLAKOS INC | 0.4% | $3.5m | 2,900,000 | 0% | held | |
| 43 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.4% | $3.1m | 140,000 | -72% | reduced |
| 44 | SEPN SEPTERNA INC | 0.4% | $3.1m | 134,202 | – | new | |
| 45 | ARTV ARTIVA BIOTHERAPEUTICS INC | 0.2% | $1.5m | 145,089 | 0% | held | |
| 46 | GLYCEUR GLYCOMIMETICS INC | 0.2% | $1.3m | 5,400,000 | – | new | |
| 47 | NUVATION BIO INC | 0.0% | $15.3k | 66,666 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.